Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).
about
Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic ApplicationsThe Evolution of the Stem Cell Theory for Heart FailureHow to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?Stimulating endogenous cardiac repairApplication of platelet-rich plasma with stem cells in bone and periodontal tissue engineeringCell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from a Rat ModelImmunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyStem cell therapy for chronic ischaemic heart disease and congestive heart failure.Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure A Systematic Review of the Existing Data and Ongoing Trials.Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT TrialsEnhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21.Morphological and functional changes in bone marrow mesenchymal stem cells in rats with heart failure.Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro.Are nestin-positive mesenchymal stromal cells a better source of cells for CNS repair?Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.Functional Effects of Delivering Human Mesenchymal Stem Cell-Seeded Biological Sutures to an Infarcted Heart.Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture.Bone Marrow Therapies for Chronic Heart Disease.Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatment.Cell transplantation as a non-invasive strategy for treating liver fibrosis.Current State of Stem Cell Therapy for Ischemic Heart Disease.Novel Biological Therapies Targeting Heart Failure: Myocardial Rejuvenation.Mesenchymal stromal cell therapy in ischemic heart disease.Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications.Left ventricular ejection fraction as therapeutic target: is it the ideal marker?Cardiac Stem Cells for Myocardial Regeneration: They Are Not Alone.Stem cell therapy for the systemic right ventricle.Mesenchymal stromal cell therapy as treatment for ischemic heart failure: the MSC-HF study.Mesenchymal stromal cells and ischemic heart disease: hitting the target?Preconditioning with far-infrared irradiation enhances proliferation, cell survival, and migration of rat bone marrow-derived stem cells via CXCR4-ERK pathwaysRationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.Electronic Cigarette Smoke Impairs Normal Mesenchymal Stem Cell Differentiation.MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells.Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.The ixCELL-DCM Trial: Rationale and Design.Emerging Therapies for Congestive Heart Failure.Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study.Stem cell therapy: from translational hurdles to new frontiers.
P2860
Q26765924-2AEB2D15-6C5A-454C-AB7E-4C2DF50FDFA0Q26769042-1B2F065B-45D4-443C-ADEF-75B30652243DQ26774939-7BC88811-B0BE-4262-A231-A18EC1F8B1F6Q26781323-0D1763CB-D6BB-43BC-825C-E90DC578B7A8Q28076740-11A70195-9C18-4CAA-85F5-9A05EE7C8ECCQ28552343-C002A64D-828C-4F5C-9616-F5A5C06CC93CQ29994669-41F57F1B-2D0C-45C3-8291-D39ECEE888E7Q30239945-7D464580-C5CE-4115-989E-DB7FA2DA258DQ31110980-2D1C55A7-72A6-4CBE-B279-11905AE53A66Q33722076-FFDB08DD-7271-4AC5-A3F6-EF1DB163D133Q33722181-892B8F2F-598D-4674-BC73-6525A4CEC5F3Q33744464-31ADFC81-9AAD-4355-BA5C-629BCA3CECA4Q33747024-DD668EBC-6729-4AEA-87DB-504DE008360FQ33757255-9B9CA403-EF7B-4EFC-A379-D59FF11D2A04Q36011869-9D9616E2-6B6A-4B1C-B041-9ABA04F3E6C0Q37213082-0D90EFC7-FAE2-44DD-A0DF-F640B7C7E306Q37419366-34BEE5B0-8B37-4EBF-A08A-19CA6F5E9C9CQ38531024-24F1F3AA-0216-4E3F-9F48-E3B618B15E43Q38626782-FB973B05-4F8E-4315-A536-A1C8C0A5110CQ38664925-B6EB5C64-A4A3-4293-A0B9-D90903C517AAQ38675565-921505CA-42B6-43F0-8AC1-98B280281487Q38697092-EE546AD5-3F67-40D1-9E8F-6F0C05752BE5Q38883960-79F0D480-4D30-431A-A9C4-E2E90659913AQ38886932-DF38565E-B3F2-4276-BD29-59128433EFD9Q39223572-49002AE4-3193-401E-89BB-30A8C13AAA62Q39364624-76E8A58A-BF01-478E-8E18-674820B811F7Q41024149-E3557F36-068F-41D1-A82D-A3763BF18E6CQ41997705-EB0260BF-EE53-4FF2-8EA6-702BBB751692Q42333634-B31C6546-5E64-48DF-80BB-0F5CBFFBDAE8Q42348036-7F06BB3B-84C6-4299-85C1-E3B9611603F5Q42652495-14030A14-0C4C-4860-899E-AFB531502736Q44100952-6244CCEF-37DA-46E5-80DC-7B3DF17AFE01Q46272932-0DEFCB2E-7B9A-4033-B149-8D9C172259CEQ47141425-59563255-5489-4AEC-B9BC-1BA6A1979EB6Q47639049-3A10BB33-40AD-49CB-BA5F-4BB777D5AE9BQ47783627-52A534FA-BF14-43A8-84AE-BB2461C747F7Q47791214-3F383F8A-B5A2-4CC8-BFC3-A6EDE5DB0D66Q47890976-47CF1B63-8EA1-49A9-BD86-DA4B0C966C1AQ48247367-D2156699-842D-4951-8F11-5E3412826EA4Q50094811-20FAE248-A0F1-479A-86A0-A4ADCEC4C184
P2860
Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Bone marrow-derived mesenchyma ...... ntrolled trial (MSC-HF trial).
@en
Bone marrow-derived mesenchyma ...... mized placebo-controlled trial
@nl
type
label
Bone marrow-derived mesenchyma ...... ntrolled trial (MSC-HF trial).
@en
Bone marrow-derived mesenchyma ...... mized placebo-controlled trial
@nl
prefLabel
Bone marrow-derived mesenchyma ...... ntrolled trial (MSC-HF trial).
@en
Bone marrow-derived mesenchyma ...... mized placebo-controlled trial
@nl
P2093
P2860
P921
P356
P1476
Bone marrow-derived mesenchyma ...... ontrolled trial (MSC-HF trial)
@en
P2093
Abbas Ali Qayyum
Anders Bruun Mathiasen
Anne Fischer-Nielsen
Erik Jørgensen
Jens Kastrup
Mandana Haack-Sørensen
Steffen Helqvist
P2860
P304
P356
10.1093/EURHEARTJ/EHV136
P577
2015-04-29T00:00:00Z